Beamtree (ASX:BMT) Insider Stuart MacDonald Buys 200,000 Shares of Stock

Beamtree Holdings Limited (ASX:BMT) insider Stuart MacDonald acquired 200,000 shares of the stock in a transaction dated Wednesday, October 15th. The stock was bought at an average cost of A$0.23 per share, with a total value of A$46,000.00.

Beamtree Stock Performance

The stock has a market cap of $84.04 million, a PE ratio of -16.41 and a beta of 1.86. The company has a debt-to-equity ratio of 3.52, a current ratio of 1.28 and a quick ratio of 1.49.

Beamtree Company Profile

Beamtree Holdings Limited develops and commercializes clinical decision support (CDS) systems to healthcare industry in Australia and internationally. The company offers RippleDown Expert, a CDS system that provides real-time patient monitoring and alerting solutions; RippleDown Auditor, that automates real-time reviews of data, ensuring accuracy across data entry, billing, specimen reception, and flagging suspected errors; and PICQ, a coding quality assessment tool for public and private hospitals, health services, and state health departments that assesses and reports clinically coded data.